CENPK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.174800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.640800E-01
Normal-vs-Stage2
5.320600E-01
Normal-vs-Stage3
9.805800E-01
Normal-vs-Stage4
7.946600E-01
Stage1-vs-Stage2
5.927800E-01
Stage1-vs-Stage3
8.280000E-01
Stage1-vs-Stage4
6.287200E-01
Stage2-vs-Stage3
4.470800E-01
Stage2-vs-Stage4
2.833800E-01
Stage3-vs-Stage4
8.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.916400E-01
Normal-vs-AfricanAmerican
7.107600E-01
Normal-vs-Asian
6.795000E-01
Caucasian-vs-AfricanAmerican
2.266200E-01
Caucasian-vs-Asian
6.972400E-01
AfricanAmerican-vs-Asian
2.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.665600E-01
Normal-vs-Female
5.607800E-01
Male-vs-Female
6.107200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.205200E-01
Normal-vs-Age(41-60Yrs)
5.498000E-01
Normal-vs-Age(61-80Yrs)
6.403400E-01
Normal-vs-Age(81-100Yrs)
5.834200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.262600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.268600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.904200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.994400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.112800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.006600E-01
Normal-vs-Daily Drinker
7.268000E-01
Normal-vs-Weekly Drinker
6.673600E-01
Normal-vs-Occasional Drinker
6.245800E-01
Normal-vs-Social Drinker
6.535600E-01
Non Drinker-vs-Daily Drinker
5.465000E-01
Non Drinker-vs-Weekly Drinker
8.346000E-01
Non Drinker-vs-Occasional Drinker
8.980600E-01
Non Drinker-vs-Social Drinker
9.403400E-01
Daily Drinker-vs-Weekly Drinker
7.531200E-01
Daily Drinker-vs-Occasional Drinker
6.569400E-01
Daily Drinker-vs-Social Drinker
6.587400E-01
Weekly Drinker-vs-Occasional Drinker
9.290800E-01
Weekly Drinker-vs-Social Drinker
9.082600E-01
Occasional Drinker-vs-Social Drinker
9.693000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.288400E-01
Normal-vs-Grade 2
9.941600E-01
Normal-vs-Grade 3
9.502000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.99349999999909E-05
Grade 1-vs-Grade 3
1.594620E-04
Grade 1-vs-Grade 4
7.288400E-01
Grade 2-vs-Grade 3
8.181800E-01
Grade 2-vs-Grade 4
9.941600E-01
Grade 3-vs-Grade 4
9.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.366600E-01
Normal-vs-NonDiabetic
5.252000E-01
Diabetic-vs-NonDiabetic
2.206200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.954000E-01
Normal-vs-NoPancreatitis
6.419600E-01
Pancreatitis-vs-NoPancreatitis
6.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.763600E-01
Normal-vs-N1
5.608400E-01
N0-vs-N1
5.872600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.542220E-01
Normal-vs-TP53-NonMutant
6.609600E-01
TP53-Mutant-vs-TP53-NonMutant
1.579860E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
